Cargando…
Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051010/ https://www.ncbi.nlm.nih.gov/pubmed/33888416 http://dx.doi.org/10.1016/j.transci.2021.103145 |
| _version_ | 1783679679260000256 |
|---|---|
| author | Sissa, Cinzia Al-Khaffaf, Ahmad Frattini, Francesco Gaiardoni, Roberta Mimiola, Elda Montorsi, Paolo Melara, Barbara Amato, Massimo Peyvandi, Flora Franchini, Massimo |
| author_facet | Sissa, Cinzia Al-Khaffaf, Ahmad Frattini, Francesco Gaiardoni, Roberta Mimiola, Elda Montorsi, Paolo Melara, Barbara Amato, Massimo Peyvandi, Flora Franchini, Massimo |
| author_sort | Sissa, Cinzia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8051010 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80510102021-04-16 Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine Sissa, Cinzia Al-Khaffaf, Ahmad Frattini, Francesco Gaiardoni, Roberta Mimiola, Elda Montorsi, Paolo Melara, Barbara Amato, Massimo Peyvandi, Flora Franchini, Massimo Transfus Apher Sci Letter to the Editor Elsevier Ltd. 2021-08 2021-04-16 /pmc/articles/PMC8051010/ /pubmed/33888416 http://dx.doi.org/10.1016/j.transci.2021.103145 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Sissa, Cinzia Al-Khaffaf, Ahmad Frattini, Francesco Gaiardoni, Roberta Mimiola, Elda Montorsi, Paolo Melara, Barbara Amato, Massimo Peyvandi, Flora Franchini, Massimo Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine |
| title | Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine |
| title_full | Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine |
| title_fullStr | Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine |
| title_full_unstemmed | Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine |
| title_short | Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine |
| title_sort | relapse of thrombotic thrombocytopenic purpura after covid-19 vaccine |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051010/ https://www.ncbi.nlm.nih.gov/pubmed/33888416 http://dx.doi.org/10.1016/j.transci.2021.103145 |
| work_keys_str_mv | AT sissacinzia relapseofthromboticthrombocytopenicpurpuraaftercovid19vaccine AT alkhaffafahmad relapseofthromboticthrombocytopenicpurpuraaftercovid19vaccine AT frattinifrancesco relapseofthromboticthrombocytopenicpurpuraaftercovid19vaccine AT gaiardoniroberta relapseofthromboticthrombocytopenicpurpuraaftercovid19vaccine AT mimiolaelda relapseofthromboticthrombocytopenicpurpuraaftercovid19vaccine AT montorsipaolo relapseofthromboticthrombocytopenicpurpuraaftercovid19vaccine AT melarabarbara relapseofthromboticthrombocytopenicpurpuraaftercovid19vaccine AT amatomassimo relapseofthromboticthrombocytopenicpurpuraaftercovid19vaccine AT peyvandiflora relapseofthromboticthrombocytopenicpurpuraaftercovid19vaccine AT franchinimassimo relapseofthromboticthrombocytopenicpurpuraaftercovid19vaccine |